🎯 check Dasatinib (BMS-354825) product page
Dasatinib is a potent ATP-competitive BCR-ABL/SRC inhibitor. It blocks MAPK signaling by binding ATP sites, inducing apoptosis.
Dasatinib (BMS-354825): Mechanism of Action
Dasatinib (BMS-354825) MOA：Targeting Src Kinase/Apoptotic Pathway for Senolytics and Anti-aging Research